Sera from lupus patients inhibit growth of P. falciparum in culture

Autoimmunity

Volumn 33, Issue 4, 2001, Pages 253-263

  Singh, S ^a   Chatterjee, S ^a   Sohoni, R ^a   Badakere, S ^a   Sharma, S ^a  

^a TATA INSTITUTE OF FUNDAMENTAL RESEARCH   (India)

Author keywords

Autoantibodies; Malaria; P0; Ribosomal phosphoprotein; Systemic lupus erythematosus

Indexed keywords

ANTIBODY; AUTOANTIBODY; IMMUNOGLOBULIN G; PHOSPHOPROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; AUTOIMMUNE DISEASE; BACTERIUM CULTURE; BLOOD SAMPLING; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS REACTION; DISEASE COURSE; GROWTH INHIBITION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOBLOTTING; IN VITRO STUDY; INDIA; MALARIA; PARASITE EXAMINATION; PLASMODIUM FALCIPARUM; PROTEIN ANALYSIS; RIBOSOME; SCREENING; SERUM; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0034840066     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.1080/08916934.2002.11873702     Document Type: Article

References (39)

1. Autoantibodies to intracellular proteins: Clinical and biological significance
2. Systemic lupus erythematosus
3. Diversity of autoantibodies to nuclear antigens
4. The 1982 revised criteria for the classification of SLE
5. Identification and chemical synthesis of a ribosomal protein antigenic determinant in systemic lupus erythematosus
6. Human acidic ribosomal phosphoproteins P0, P1 and P2: Analysis of cDNA clones, in vitrosynthesis and assembly
7. Properties of the ribosomal P2 protein autoantigen are similar to those of foreign protein antigens
8. Association between lupus psychosis and anti-ribosomal P protein antibodies
9. Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus
10. Identification of ribosomal protein autoantigens
11. Novel proteins of Plasmodium falciparum identified by differential immunoscreening using immune and patient sera
12. Characterization of domains of the phosphoriboprotein P0 of Plasmodium falciparum
13. Identification of the Leishmania infantum P0 ribosomal protein epitope in canine visceral leishmaniasis
14. Characterization of the C-terminal region of a Trypanozoma cruzi 38-kDa ribosomal P0 protein that does not react with Lupus anti-P autoantibodies
15. The Trypanosoma cruzi ribosomal P protein family: Classification and antigenicity
16. Characterization of P0, a ribosomal phosphoprotein of Plasmodium falciparum
17. Cloning of a ribosomal phosphoprotein P0 gene homologue from Plasmodium falciparum
18. Synchronisation of Plasmodium falciparum erythrocytic stages in culture
19. A procedure for harvesting of mammalian plasmodia
20. Single step purification of polypeptides expressed in Escherichia colias fusions with glutathione-S-transferase
21. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
22. Lupus autoantibodies target ribosomal P proteins
23. Monoclonal antibodies against eukaryotic ribosomes. Use to characterize a ribosomal protein not previously identified and antigenically related to the acidic phosphoproteins P1/P2
24. Antibodies to ribosomal P proteins of Trypanosoma cruzi in Chagas disease possess functional autoreactivity with heart tissue and differ from anti-P autoantibodies in lupus
25. Ribosomal protein P0, contrary to phosphoproteins P1 and P2, is required for ribosome activity and Saccharomyces cerevisiae viability
26. Autoantibodies to the ribosomal P proteins react with a plasma membrane-related target on human cells
27. The expression of acidic ribosomal phosphoproteins on the surface membrane of different tissues in autoimmune and normal mice which are the target molecules for anti-double-stranded DNA antibodies
28. Drosophila ribosomal protein P0 contains apurinic/apyrimidinic endonuclease activity
29. A prospective study on anti-ribosomal P proteins in two cases of familial lupus and recurrent psychosis
30. Antibodies to protein P in systemic lupus erythematosus
31. Fluctuations of antibody to ribosomal P proteins correlate with appearance and remission of nephritis in SLE
32. Serological indices in Tanzania. II. Antinuclear factor and malarial indices in populations living at different altitudes
33. Immunological abnormalities in Caucasians with malaria
34. Anti-ssDNA and antinuclear antibodies in human malarias
35. Autoantibodies in sera of Thai patients with Plasmodium falciparum infection
36. Anti-nuclear and anti-smooth muscle antibodies in Caucasians, Africans and Asians with acute malaria
37. Antibodies against the ribosomal phosphoprotein P0 of Plasmodium falciparum protect mice against challenge with P. yoelii
38. Immunization of mice with recombinant L7/L12 ribosomal protein confers protection against Brucella abortus infection
39. Plasmodium falciparum ribosomal P2 protein gene expression is independent of the developmentally regulated rRNAs